Position in NTRA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$979,120
+$278,556 QoQ
Shares Held
3,607
+3.0% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#444
of 844 holders
Holding Since
Mar 2024
10 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NTRA Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026KENNEDY CAPITAL MANAGEMENT LLC holds $76,192,428 across 12 Diagnostics & Research names. NTRA ranks #11 (1.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PSNL |
Personalis, Inc.
|
2,364,282 | $31,681,378 | |
| 2 | CRL |
Charles River Laboratories International, Inc.
|
43,719 | $9,915,032 | |
| 3 | CSTL |
Castle Biosciences Inc
|
348,371 | $8,308,648 | |
| 4 | TMO |
Thermo Fisher Scientific Inc.
|
13,440 | $6,738,278 | |
| 5 | A |
Agilent Technologies, Inc.
|
43,014 | $5,713,549 | |
| 6 | ICLR |
Icon PLC
|
19,993 | $3,472,984 | |
| 7 | VCYT |
Veracyte, Inc.
|
52,978 | $3,111,397 | |
| 8 | DHR |
Danaher Corp /De/
|
14,347 | $2,732,816 |
All Filings in NTRA
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $979,120 | 3,607 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $700,564 | 3,503 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $736,524 | 3,215 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $518,323 | 3,220 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $281,791 | 1,668 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $484,187 | 3,424 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $535,212 | 3,381 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $349,620 | 2,754 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $437,599 | 4,041 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $291,757 | 3,190 | Shares | Sole | 2024-05-15 | |
| No filing history on record for this holder in this stock. | ||||||